Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients
AMERICAN JOURNAL OF TRANSPLANTATION
Authors: Quteineh, Lina; Wojtowicz, Agnieszka; Bochud, Pierre-Yves; Crettol, Severine; Vandenberghe, Frederik; Venetz, Jean-Pierre; Manuel, Oriol; Golshayan, Dela; Lehmann, Roger; Mueller, Nicolas J.; Binet, Isabelle; van Delden, Christian; Steiger, Jurg; Mohacsi, Paul; Dufour, Jean-Francois; Soccal, Paola M.; Kutalik, Zoltan; Marques-Vidal, Pedro; Vollenweider, Peter; Recher, Mike; Hess, Christoph; Pascual, Manuel; Eap, Chin B.
Abstract
New-onset diabetes mellitus after transplantation (NODAT) is a complication following solid organ transplantation (SOT) and may be related to immune or inflammatory responses. We investigated whether single nucleotide polymorphisms (SNPs) within 158 immune- or inflammation-related genes contribute to NODAT in SOT recipients. The association between 263 SNPs and NODAT was investigated in a discovery sample of SOT recipients from the Swiss Transplant Cohort Study (STCS, n(1) = 696). Positive results were tested in a first STCS replication sample (n(2) = 489) and SNPs remaining significant after multiple test corrections were tested in a second SOT replication sample (n(3) = 156). Associations with diabetic traits were further tested in several large general population-based samples (n > 480 000). Only SP110 rs2114592C>T remained associated with NODAT in the STCS replication sample. Carriers of rs2114592-TT had 9.9 times (95% confidence interval [CI]: 3.22-30.5, P = .00006) higher risk for NODAT in the combined STCS samples (n = 1184). rs2114592C>T was further associated with NODAT in the second SOT sample (odds ratio: 4.8, 95% CI: 1.55-14.6, P = .006). On the other hand, SP110 rs2114592C>T was not associated with diabetic traits in population-based samples, suggesting a specific gene-environment interaction, possibly due to the use of specific medications (ie, immunosuppressants) in transplant patients and/or to the illness that may unmask the gene effect.
Identification of SP110 in horse (Equus caballus): Isolation of novel splice variants and evidence of activation effects on macrophages
TUBERCULOSIS
Authors: Chen, Qi; Tong, Qi; Ge, Hengtao; Li, Wenzhong; Liu, Jun; Wang, Yongsheng; Guo, Zekun; Quan, Fusheng; Zhang, Yong
Abstract
SP110 has previously shown to be a genetic determinant of host resistance to the intracellular pathogen infection in mouse and human. However, its relevant biological information in large non-primate animals still remains unknown. Here we report the novel discovery and characterization of three transcript variants of horse SP110. The transcript variant 1 (Tv1) of horse SP110 with the longest open reading frame has four domains (Sp100, SAND, PHD and Bromo domain). Tv2 and Tv3 share the same N-terminal sequence as Tv1, which contains Sp100 and. SAND. We show that Tv2 is generated from alternative splicing and deletion of Exon17-Exon18 segment, while Tv3 is generated by pre-mature transcriptional termination at Exon 16. Furthermore, we demonstrate that the heterologous expression of horse SP110 variants stimulate macrophages into an activation-like phenotype. The macrophages underwent a shift in enhancing the secretion of cytokines (interleukin-1 (IL -1) and TNF-alpha) and accelerating inducible nitric oxide synthase (iNOS) activity, and eventually went into apoptotic cell death. Intriguingly, horse SP110 Tv1 showed more capability to trigger the immune activities compared to Tv2 and Tv3. To our knowledge, the identification of SP110 transcript variants from horse is the first report on biological function of SP110 in perissodactyla animals. (C) 2016 Elsevier Ltd. All rights reserved.